Genvoya and Cellulitis - a phase IV clinical study of FDA data
Summary:
Cellulitis is reported as a side effect among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 50-59 old, also take Truvada, and have Psoriasis.
The phase IV clinical study analyzes which people have Cellulitis when taking Genvoya. It is created by eHealthMe based on reports of 13,480 people who have side effects when taking Genvoya from the FDA, and is updated regularly.
What is Genvoya?
Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.
What is Cellulitis?
Cellulitis (infection under the skin) is found to be associated with 2,081 drugs and 2,340 conditions by eHealthMe. Check the latest studies of Cellulitis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13,480 people reported to have side effects when taking Genvoya.
Among them, 17 people (0.13%) have Cellulitis.

Among these 17 people:
What is the gender of people who have Cellulitis when taking Genvoya? *
- female: 18.75 %
- male: 81.25 %
What is the age of people who have Cellulitis when taking Genvoya? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 28.57 %
- 40-49: 14.29 %
- 50-59: 42.86 %
- 60+: 14.29 %
What are other drugs people take besides Genvoya? *
- Truvada: 10 people, 58.82%
- Zyrtec: 5 people, 29.41%
- Clobex: 5 people, 29.41%
- Cosentyx: 5 people, 29.41%
- Xarelto: 5 people, 29.41%
- Atripla: 4 people, 23.53%
- Norvir: 3 people, 17.65%
- Bactrim: 3 people, 17.65%
- Reyataz: 3 people, 17.65%
- Rivaroxaban: 3 people, 17.65%
What are other side effects people have besides Cellulitis? *
- Acute Kidney Failure: 4 people, 23.53%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 23.53%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 23.53%
- Pharyngitis Streptococcal (inflammation of the pharynx caused by infection from. streptococcus): 4 people, 23.53%
- Bone Loss: 4 people, 23.53%
- Sinusitis (inflammation of sinus): 4 people, 23.53%
- Sleep Apnea Syndrome: 4 people, 23.53%
- Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 23.53%
- Stress And Anxiety: 4 people, 23.53%
- Bone Density Decreased: 4 people, 23.53%
What are the existing conditions these people have? *
- Psoriasis (immune-mediated disease that affects the skin): 5 people, 29.41%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.88%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.88%
- Parkinson's Disease: 1 person, 5.88%
- High Blood Pressure: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Genvoya and have Cellulitis?
- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Genvoya:
- Genvoya (13,538 reports)
Cellulitis treatments and more:
- Cellulitis (75,291 reports)
How severe was Cellulitis and when was it recovered:
Expand to all the drugs that have ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Genvoya:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cellulitis:
- Cellulitis (2,081 drugs)
Browse all the conditions that are associated with Cellulitis:
- Cellulitis (2,340 conditions)
Related publications that referenced our studies
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Genvoya) and Genvoya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Valturna vs. Doxazosin Mesylate, side effect and effectiveness comparison - 12 seconds ago
- Could Copegus cause Chronic Thyroiditis? - 29 seconds ago
- Ruptured Eardrum and drugs of ingredients of fexofenadine hydrochloride - 31 seconds ago
- Could Colchicine cause Abasia? - 36 seconds ago
- Drug interactions of Aspirin and Chromium Chloride - 40 seconds ago
- Could Gemcitabine cause Diffuse Interstitial Lung Disease? - 42 seconds ago
- Ranitidine Hydrochloride vs. Naproxen, side effect and effectiveness comparison - 55 seconds ago
- Could Theophyl cause Churg Strauss Syndrome? - 59 seconds ago
- Could Capecitabine cause Blood Pressure Fluctuation? - 59 seconds ago
- Drug interactions of Sporanox and Allopurinol - a minute ago